Evaluating Blood–Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study
ABSTRACT Acetylcholinesterase inhibitors (AChEIs) remain the first‐line treatment for Alzheimer's disease. However, these drugs are largely symptomatic and often associated with adverse effects. This study aimed to evaluate novel pharmacophores for their in vitro AChEI activity, blood–brain bar...
Saved in:
| Main Authors: | L. M. Maboko, A. Theron, J.‐L. Panayides, W. Cordier, D. Fisher, V. Steenkamp |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Pharmacology Research & Perspectives |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/prp2.70043 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thiamine and Thiamine Pyrophosphate as Non-Competitive Inhibitors of Acetylcholinesterase—Experimental and Theoretical Investigations
by: Łukasz Szeleszczuk, et al.
Published: (2025-01-01) -
Assessment of Potential Acetylcholinesterase Inhibitors: An In Silico Study
by: Nathaniel Ohiemi Amedu, et al.
Published: (2024-08-01) -
Amperometric acetylcholinesterase biosensor for physostigmine determination
by: R.R. Davletshina, et al.
Published: (2018-03-01) -
Hesperidoside abolishes dichlorvos-mediated neurotoxicity in rats by suppressing oxidative stress, acetylcholinesterase inhibition, and NF-κB-p65/p53/caspase-3-mediated apoptosis
by: Adio J. Akamo, et al.
Published: (2025-02-01) -
Virtual screening of bioactive compounds from the lamiaceae family as acetylcholinesterase inhibitors for alzheimer’s disease
by: Harry Noviardi, et al.
Published: (2025-07-01)